CA957943A - Process for isolating a fibrin-stabilizing factor from human placenta extracts - Google Patents

Process for isolating a fibrin-stabilizing factor from human placenta extracts

Info

Publication number
CA957943A
CA957943A CA130,488A CA130488A CA957943A CA 957943 A CA957943 A CA 957943A CA 130488 A CA130488 A CA 130488A CA 957943 A CA957943 A CA 957943A
Authority
CA
Canada
Prior art keywords
fibrin
isolating
human placenta
stabilizing factor
placenta extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA130,488A
Other languages
English (en)
Other versions
CA130488S (en
Inventor
Oswald Zwisler
Hans Biel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA957943A publication Critical patent/CA957943A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • C12N9/1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA130,488A 1970-12-22 1971-12-20 Process for isolating a fibrin-stabilizing factor from human placenta extracts Expired CA957943A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2063070A DE2063070C3 (de) 1970-12-22 1970-12-22 Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung

Publications (1)

Publication Number Publication Date
CA957943A true CA957943A (en) 1974-11-19

Family

ID=5791794

Family Applications (1)

Application Number Title Priority Date Filing Date
CA130,488A Expired CA957943A (en) 1970-12-22 1971-12-20 Process for isolating a fibrin-stabilizing factor from human placenta extracts

Country Status (15)

Country Link
JP (1) JPS5421402B1 (nl)
AT (1) AT310941B (nl)
AU (1) AU432182B2 (nl)
BE (1) BE777136A (nl)
BR (1) BR7108490D0 (nl)
CA (1) CA957943A (nl)
CH (1) CH575235A5 (nl)
DE (1) DE2063070C3 (nl)
DK (1) DK127227B (nl)
ES (1) ES398016A1 (nl)
FR (1) FR2119009B1 (nl)
GB (1) GB1380056A (nl)
IL (1) IL38403A (nl)
NL (1) NL159582B (nl)
SE (1) SE371930B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454745B (sv) * 1982-12-10 1988-05-30 Cubana Importadora Y Exportado Produkt for att stimulera syntesen av melanotiskt pigment i huden vid botande av vigiligo
FR2600078B1 (fr) * 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
WO1991000098A1 (en) * 1989-06-23 1991-01-10 Kishinevsky Selskokhozyaistvenny Institut Imeni M.V.Frunze Anti-inflammatory preparation and method of obtaining it
DE19508192A1 (de) 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt

Also Published As

Publication number Publication date
BR7108490D0 (pt) 1973-05-08
DE2063070C3 (de) 1975-07-24
AT310941B (de) 1973-10-25
NL7117363A (nl) 1972-06-26
SE371930B (nl) 1974-12-09
AU432182B2 (en) 1973-02-15
CH575235A5 (nl) 1976-05-14
AU3708871A (en) 1973-02-15
DE2063070A1 (de) 1972-06-29
IL38403A0 (en) 1972-02-29
GB1380056A (en) 1975-01-08
DE2063070B2 (de) 1974-12-05
BE777136A (fr) 1972-06-22
NL159582B (nl) 1979-03-15
FR2119009B1 (nl) 1975-03-14
ES398016A1 (es) 1974-07-16
IL38403A (en) 1975-04-25
JPS5421402B1 (nl) 1979-07-30
FR2119009A1 (nl) 1972-08-04
DK127227B (da) 1973-10-08

Similar Documents

Publication Publication Date Title
CA957802A (en) Vascular prosthetic
CA1008849A (en) Ap-glycoproteins and process for isolating them
AU459934B2 (en) Multi-circuit moldule and method for making
CA957943A (en) Process for isolating a fibrin-stabilizing factor from human placenta extracts
CA1003332A (en) Process for isolating a fibrin-stabilizing factor from human placenta extracts
CA933288A (en) Method of operating piezoelectric transformers
CA971163A (en) Methods for the fractionation of amyloses
CA963808A (en) Perspiration-responsive aerosol deodorant
AU435492B2 (en) Process for isolating a fibrin-stabilizing factor
AU5850169A (en) Method of covering
CA978908A (en) Aerosol valve
CA858316A (en) Aerosol filter
CA837836A (en) Language aid system
CA835418A (en) Cycloaliphatic alkylhydroxyphenylalkanoates
CA960220A (en) Cycloalkyl p-aminobenzoates
CA902645A (en) Process for the isolation of d-isothujone
CA835196A (en) Aerosol valve unit
CA898692A (en) Process for the isolation of calcitonin
CA787897A (en) Method of making peptides
CA854652A (en) Soil-treating procedure
AU445995B2 (en) Isolating switch
CA777183A (en) Method for the preparation of arylisothiocyanates
CA776702A (en) Method for the preparation of arylisothiocyanates
CA861487A (en) Fractionation system
AU448691B2 (en) Anticoagulant isolation